Veriheal

MARCH 20, 2023

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Smith cited results from clinical trials showing that MDMA holds promise in the treatment of PTSD. Missouri Rep.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

Cannabis Law Report

FEBRUARY 10, 2022

A look at key research and clinical trials that were published in 2021, with analysis of themes like microdosing and SSRI interactions. In the final section we share the key trends we will be following as we look ahead to 2022. Access the PDF here. and Canada.

Clinical Trials 52

Clinical Trials Microdosing Pharmaceutical Policy 52

The Cannigma

DECEMBER 12, 2022

Turning down activity in the DMN allows better access to new areas of the brain, which can boost creativity and improve problem solving. What is microdosing? A microdose is a dose that does not elicit a perceivable intoxicating or trip-like effect. Microdosing is possible in theory, but there are no current recommendations.

History 119

History Microdosing Research and Development Clinical Trials 119

Cannabis Law Report

MARCH 3, 2022

The team at Microdose, the world’s biggest medical psychedelic conference , said the country’s move to permit Med Plant Science Ltd to produce psychedelic compounds makes it the first country to legalize all psychedelic medicine. . The eventual trials would target PTSD, addiction, alcoholism, depression, and anxiety. and Europe.

Research and Development 52

Research and Development Medicine Clinical Trials Microdosing 52